Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi Post author:Sam Post published:January 31, 2018 Post category:BioPharma Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace You Might Also Like GOP Congressman Lost $16.7 Million in Single Day on This Tanking Biotech Stock June 27, 2017 Future Biotech Giants: 11 Life Science Entrepreneurs Under 30 February 22, 2017 venBio Calls On Immunomedics Stockholders To Support Meaningful Change January 29, 2017